ATMP Sweden is a national coordination and communication network aimed at accelerating patient access to safe and effective medicines based on recombinant genes, live cells and/or tissue engineering. This new class of medicines are classified as Advanced Therapy Medicinal Products (ATMPs) by the European Medicines Agency.
Miclev will be exhibiting at ATMP Sweden 2025 Conference, November 27-28 in Gothenburg and you are welcome to visit us!
Read more & register